PolarityTE™ Provides Business Updates on Clinical Use of SkinTE: Regeneration of Full-Thickness Skin Pharmaceutical Investing
EyeGate Announces Top-Line Results for Phase 2b Trial of EGP-437 in Cataract Surgery Pharmaceutical Investing
Sorrento’s and Yuhan’s Joint Venture, ImmuneOncia, receives Approval to begin clinical trial of Anti-PD-L1 Biotech Investing
Paratek Completes Submission of New Drug Applications to U.S. Food and Drug Administration Pharmaceutical Investing
AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for Feraheme Pharmaceutical Investing
MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression Biotech Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
